Skip to main content
SpringerLink
Log in

Extracellular Matrix and Mesothelioma: Some Clues to the Invasive Behavior of Mesothelioma

  • Chapter
Malignant Mesothelioma

  • 948 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Klemperer P, Rabin CB. Primary neoplasms of the pleura. Arch Pathol 1931;11:385–412.

    Google Scholar 

  2. Semb G. Diffuse malignant pleural mesothelioma: a clinicopathological study of 10 fatal cases. Acta Chir Scand 1963;126:78–91.

    PubMed  CAS  Google Scholar 

  3. Wilson GE, Hasleton PS, Chatterjee AK. Desmoplastic malignant mesothelioma: a review of 17 cases. J Clin Pathol 1992;45:295–298.

    PubMed  CAS  Google Scholar 

  4. Ruffie P, Feld R, Minkin S, et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 1989;7:1157–1168.

    PubMed  CAS  Google Scholar 

  5. Moskal TL, Urschel JD, Anderson T, Antkowiak JG, Takita H. Malignant pleural mesothelioma: a problematic review. Surg Oncol 1999;7:5–12.

    Article  Google Scholar 

  6. Chahinian AP, Pajak TF, Holland JF, Norton L, Ambinder RM, Mandel EM. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med 1982;96:746–755.

    PubMed  CAS  Google Scholar 

  7. Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest 1983;77:321–343.

    Article  PubMed  CAS  Google Scholar 

  8. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001;411:375–379.

    Article  PubMed  CAS  Google Scholar 

  9. Timpl R, Dziadek M. Structure, development, and molecular pathology of basement membranes. Int Rev Exp Pathol 1986;29:1–112.

    PubMed  CAS  Google Scholar 

  10. Akiyama Y, Jung S, Salhia B, et al. Hyaluronate receptors mediating glioma cell migration and proliferation. J Neurooncol 2001;53:115–127.

    Article  PubMed  CAS  Google Scholar 

  11. Klagsburn M, Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell 1991;67:229–231.

    Article  Google Scholar 

  12. Roberts AB, McCune BK, Sporn MB. TGF-beta regulation of extracellular matrix. Kidney Int 1992;41:557–559.

    PubMed  CAS  Google Scholar 

  13. Damsky C, Sutherland A, Fisher S. Extracellular matrix 5: adhesive interactions in early mammalian embryogenesis, implantation and placentation. FASEB J 1993;7:1320–1329.

    PubMed  CAS  Google Scholar 

  14. Damsky CH, Werb Z. Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr Opin Cell Biol 1992;4:772–781.

    Article  PubMed  CAS  Google Scholar 

  15. Ingber DE, Folkman J. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol 1989;109:317–330.

    Article  PubMed  CAS  Google Scholar 

  16. Carter WG, Kaur P, Gil SG, Gahr PJ, Wayner EA. Distinct functions for integrins alpha 3 beta 1 in focal adhesions and alpha 6 beta 4/bullous pemphigoid antigen in a new stable anchoring contact (SAC) of keratinocytes: relation to hemidesmosomes. J Cell Biol 1990;111:3141–3154.

    Article  PubMed  CAS  Google Scholar 

  17. Timpl R. Structure and biological activity of basement membrane proteins. Eur J Biochem 1989;180:487–502.

    Article  PubMed  CAS  Google Scholar 

  18. Bissell MJ, Hall GH, Parry G. How does the extracellular matrix direct gene expression? J Theor Biol 1982;99:31–68.

    Article  PubMed  CAS  Google Scholar 

  19. Lin CQ, Bissell MJ. Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J 1993;7:737–743.

    PubMed  CAS  Google Scholar 

  20. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993;9:541–573.

    Article  PubMed  CAS  Google Scholar 

  21. Liotta LA. Tumor invasion and metastases—role of the extracellular matrix: Rhodes memorial award lecture. Cancer Res 1986;46:1–7.

    PubMed  CAS  Google Scholar 

  22. Liotta LA, Rao CN, Barsky SH. Tumor invasion and the extracellular matrix. Lab Invest 1983;49:636–649.

    PubMed  CAS  Google Scholar 

  23. Yurchenco PD, Schittny JC. Molecular architecture of basement membranes. FASEB J 1990;4:1577–1590.

    PubMed  CAS  Google Scholar 

  24. Humphries MJ, Olden K, Yamada KM. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986;233:467–470.

    PubMed  CAS  Google Scholar 

  25. Hynes RO. Integrins: a family of cell surface receptors. Cell 1987;48:549–554.

    Article  PubMed  CAS  Google Scholar 

  26. Ruoslahti E. Integrins. J Clin Invest 1991;87:1–5.

    PubMed  CAS  Google Scholar 

  27. Rao C, Castronovo V, Schmott MC, et al. Evidence for a precursor of the high-affinity metastasis associated murine laminin receptor. Biochemistry 1989;28:7476–7486.

    Article  PubMed  CAS  Google Scholar 

  28. Aznavoorian S, Stracke ML, Krutzsch H, Schiffmann E, Liotta LA. Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells. J Cell Biol 1990;110:1427–1438.

    Article  PubMed  CAS  Google Scholar 

  29. Kadler K. Extracellular matrix I. Fibril-forming collagens. Protein Profile 1994;1:519–638.

    PubMed  CAS  Google Scholar 

  30. Yurchenco PD. Assembly of laminin and collagen type IV into basement membrane networks. In: Yurchenco PD, Birk DE, Mecham RP, eds. Extracellular Matrix Assembly and Structure. San Diego: Academic Press, 1994.

    Google Scholar 

  31. Tlsty TD. Stromal cells can contribute oncogenic signals. Semin Cancer Biol 2001;11:97–104.

    Article  PubMed  CAS  Google Scholar 

  32. Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA. Molecular aspects of tumor cell invasion and metastasis. Cancer 1993;71:1368–1383.

    Article  PubMed  CAS  Google Scholar 

  33. McCarthy J, Turely EA. Effects of extracellular matrix components on cell locomotion. Crit Rev Oral Biol Med 1993;4:619–637.

    PubMed  CAS  Google Scholar 

  34. Klominek J, Baskin B, Hauzenberger D. Platelet-derived growth factor BB is a chemoattractant for human malignant mesothelioma cells and its action is mediated through platelet derived growth ß interactions. Clin Exp Metastasis 1998;16:529–539.

    Article  PubMed  CAS  Google Scholar 

  35. Doerr ME, Jones JI. The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J Biol Chem 1996;271:2443–2447.

    Article  PubMed  CAS  Google Scholar 

  36. Wells A, Kassis J, Solava J, Turner T, Lauffenburger DA. Growth factor-induced cell motility in tumor invasion. Acta Oncol 2002;41:124–130.

    Article  PubMed  CAS  Google Scholar 

  37. Wang NS. Ultrastructure of rabbit pleura. Am Rev Respir Dis 1974;110:623–633.

    PubMed  CAS  Google Scholar 

  38. Legrand M, Pariénte R, André J, Chrétien J, Brouet G. Ultrastructure de la plèvre pariétale humaine. Presse Med 1971;79:2515–2520.

    PubMed  CAS  Google Scholar 

  39. Whitaker D, Papadimitriou J. Mesothelial healing: morphological and kinetic investigations. J Pathol 1985;145:159–175.

    Article  PubMed  CAS  Google Scholar 

  40. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990;37:1563–1570.

    PubMed  CAS  Google Scholar 

  41. Bermudez E, Everitt J, Walker C. Expression of growth factor and growth factor receptor RNA in rat pleural mesothelial cells in culture. Exp Cell Res 1990;190:91–98.

    Article  PubMed  CAS  Google Scholar 

  42. Davila RM, Crouch EC. Role of mesothelial and submesothelial stromal cells in matrix remodeling following pleural injury. Am J Pathol 1993;142:547–555.

    PubMed  CAS  Google Scholar 

  43. Pinchon MC, Ebert RV. Pleural permeability in rat I. Ultrastructural basis. Cell Biol 1980;37:269–272.

    Google Scholar 

  44. Agostoni E, Zocchi L. Mechanical coupling and liquid exchanges in the pleural space. Clin Chest Med 1998;19:241–260.

    Article  PubMed  CAS  Google Scholar 

  45. Hirsch A, Bernaudin JF, Nebut M, Soler P. The pleural mesothelium, structure and function. Bull Eur Physiopathol Respir 1976;12:367–406.

    Google Scholar 

  46. Borenstein P, Sage H. Structurally distinct collagen types. Annu Rev Biochem 1980;49:957–1003.

    Article  Google Scholar 

  47. Gay RE, Rhodes RK. Immunolocalisation of the Genetically Distinct Collagen Types in the Pathology of Connective Tissue. New York: Marcel Dekker, 1986.

    Google Scholar 

  48. Isoda K, Maeda T, Hamamoto Y. Collagen-producing mesothelial cells in Adriamycin-induced pleuritis in rat. Acta Pathol Jpn 1987;37:1305–1317.

    PubMed  CAS  Google Scholar 

  49. Bork P. The modula structure of vertebrate collagens. FEBS Lett 1992;100:49–54.

    Article  Google Scholar 

  50. Van Der Rest M, Garrone R. Collagen family of proteins. FASEB J 1991;5:2814–2823.

    PubMed  Google Scholar 

  51. Harvey W, Amlot PL. Collagen production by human mesothelial cells in vitro. J Pathol 1983;139:337–347.

    Article  PubMed  CAS  Google Scholar 

  52. Godwin MC. Diffuse mesotheliomas: with comment on their relation to localised fibrous mesotheliomas. Cancer Metastasis Rev 1957;10:298–319.

    CAS  Google Scholar 

  53. McCoughey WTE. Primary tumours of the pleura. Ann NY Acad Sci 1958;132:603–613.

    Google Scholar 

  54. Suzuki Y, Chahinian P, Ohnuma T. Comperative studies of human malignant mesothelioma in vivo, in xenografts in nude mice, and in vitro. Cancer 1987:334–344.

    Google Scholar 

  55. Suzuki Y, Churg J, Kannerstein M. Ultrastructure of human malignant diffuse mesothelioma. Am J Pathol 1976;85:241–262.

    PubMed  CAS  Google Scholar 

  56. Churg J, Rosen SH, Moolten S. Histological characteristics of mesothelioma associated with asbestos. Ann NY Acad Sci 1965;132:614–622.

    PubMed  CAS  Google Scholar 

  57. Cantin R, Al-Jabi M, McCoughey WTE. Desmoplastic diffuse mesothelioma. Am J Surg Pathol 1982;6:215–222.

    Article  PubMed  CAS  Google Scholar 

  58. Guarino M, Christensen L. Immunohistochemical analysis of extracellular matrix components in synovial sarcoma. J Pathol 1994;172:279–286.

    Article  PubMed  CAS  Google Scholar 

  59. Valensi QJ. Desmoplastic malignant melanoma: a light and electron microscopic study of two cases. Cancer 1979;43:1148–1155.

    Article  PubMed  CAS  Google Scholar 

  60. Adams VI, Unni KK. Diffuse malignant mesothelioma of pleura: diagnostic criteria based on an autopsy study. Am J Clin Pathol 1984;82:15–23.

    PubMed  CAS  Google Scholar 

  61. Kataoka H, Wickström B, Klominek J, Gay RE, Gay S, Hjerpe A. Immunocytochemical demonstration of collagen types I and IV in cells isolated from malignant mesothelioma and in lung cancer cell lines. Lung Cancer 1990;6:16–27.

    Article  Google Scholar 

  62. Kallianpur AR, Carstens PH, Liotta LA, Frey KP, Siegal GP. Immunoreactivity in malignant mesotheliomas with antibodies to basement membrane components and their receptors. Modern Pathol 1990;3:11–18.

    CAS  Google Scholar 

  63. Di Muzio M, Spoletini L, Strizzi L, et al. Basal lamina reduplication in malignant epithelioid pleural mesothelioma. Ultrastruct Pathol 1998;22:467–475.

    PubMed  Google Scholar 

  64. Alvarez-Fernandez E, Diez-Nau MD. Malignant fibrosarcomatous mesothelioma and benign pleural fibroma (localized fibrous mesothelioma) in tissue culture. Cancer 1979;43:1658–1663.

    Article  PubMed  CAS  Google Scholar 

  65. Behbehani AM, Hunter WJ, Chapman AL, Lin F. Studies of human mesothelioma. Hum Pathol 1982;13:862–866.

    PubMed  CAS  Google Scholar 

  66. Klominek J, Robért K-H, Sundqvist K-G. Chemotaxis and haptotaxis of human malignant mesothelioma cells. Effects of fibronectin, laminin, type IV collagen and an autocrine motility factor-like substance. Cancer Res 1993;53:4376–4382.

    PubMed  CAS  Google Scholar 

  67. Scarpa S, Giuffrida A, Fazi M, et al. Migration of mesothelioma cells correlates with histotype-specific synthesis of extracellular matrix. Int J Mol Med 1999;4:67–71.

    PubMed  CAS  Google Scholar 

  68. Harvey P, Clark IM, Jaurand M-C, Edwards DR. Hepatocyte growth factor/scatter factor enhance the invasion of mesothelioma cell lines and the expression of matrix metalloproteases. Br J Cancer 2000;83:1147–1153.

    Article  PubMed  CAS  Google Scholar 

  69. Harvey P, Warn A, Newman P, Perry LJ, Ball RY, Warn RM. Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas. J Pathol 1996;180:389–394.

    Article  PubMed  CAS  Google Scholar 

  70. Klominek J, Liu Z, Baskin B, Hauzenberger D. Human hepatocyte growth factor/scatter factor stimulats chemotaxis and growth of malignant mesothelioma cells through c-met receptor. Int J Cancer 1998;76:240–249.

    Article  PubMed  CAS  Google Scholar 

  71. Klominek J, Sumitran Karuppan S, Hauzenberger D. Differential motile response of human malignant mesothelioma cells to fibronectin, laminin and collagen type IV: the role of b1 integrins. Int J Cancer 1997;72:1034–1044.

    Article  PubMed  CAS  Google Scholar 

  72. Ruoslahti E, Vaheri A. Novel human serum protein from fibroblast plasma membrane. Nature 1974;248:789–791.

    Article  PubMed  CAS  Google Scholar 

  73. Hynes RO, Yamada KM. Fibronectins: multifunctional modular glycoproteins. J Cell Biol 1982;95:369–377.

    Article  PubMed  CAS  Google Scholar 

  74. Hynes RO. Fibronectins. New York: Springer-Verlag, 1990.

    Google Scholar 

  75. Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem 1988;57:375–413.

    Article  PubMed  CAS  Google Scholar 

  76. Woods A, Couchman JR. Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments. EMBO J 1986;5:665–670.

    PubMed  CAS  Google Scholar 

  77. Christensen L. The distribution of fibronectin, laminin and tetranectin in human breast cancer with special attention to the extracellular matrix. APMIS 1992;suppl 26.

    Google Scholar 

  78. Loridon-Rosa B, Vielh P, Cuadrado C, Buriton P. Comperative distribution of fibronectin and vitronection in human breast and colon carcinomas. An immunofluorescence study. Am J Clin Pathol 1988;90:7–16.

    PubMed  CAS  Google Scholar 

  79. Christiansen L, Nielsen M. Stromal fibronectin staining pattern and metastasizing ability of human breast carcinoma. Cancer Research 1988:6227–6233.

    Google Scholar 

  80. Rennard SI, Jaurand M-C, Bignon J, et al. Role of pleural mesothelial cells in the production of the submesothelial connective tissue matrix of lung. Am Rev Respir Dis 1984;130:267–274.

    PubMed  CAS  Google Scholar 

  81. Kinnula VL, Linnala A, Viitala E, Linnainmaa K, Virtanen I. Tenascin and fibronectin expression in human mesothelial cells and pleural mesothelioma cell-line cells. Am J Respir Cell Mol Biol 1998;19:445–452.

    PubMed  CAS  Google Scholar 

  82. Ferriola PC, Stewart W. Fibronectin expression and organization in mesothelial and mesothelioma cells. Am J Physiol 1996;271:L804–L812.

    PubMed  CAS  Google Scholar 

  83. Siri A, Carnemolla B, Raffanti S, Castellani P, Balzano E, Zardi L. Fibronectin concentrations in pleural effusions of patients with malignant and non-malignant diseases. Cancer Lett 1984;22:1–9.

    Article  PubMed  CAS  Google Scholar 

  84. Klominek J, Hauzenberger D, Sundqvist K-G. Platelet derived growth factor (PDGF) is a chemoattractant for human malignant mesothelioma cells. Keystone Symposia Abstract 1994.

    Google Scholar 

  85. Palmer U, Liu Z, Broomé U, Klominek J. Epidermal growth factor receptor ligands are chemoattractants for normal human mesothelial cells. Eur Respir J 1999;14:405–411.

    Article  PubMed  CAS  Google Scholar 

  86. Beck K, Hunter I, Engel J. Structure and function of laminin: anatomy of a multidomain glycoprotein. FASEB J 1990;4:148–160.

    PubMed  CAS  Google Scholar 

  87. Timpl R, Rodhe H, Gehron Robey P, Rennard SI, Foidart JM, Martin GR. Laminin—a glucoprotein from basement membranes. J Biol Chem 1979;254:97–120.

    Google Scholar 

  88. Timpl R, Brown JC. The laminins. Matrix Biol 1994;14:275–281.

    Article  PubMed  CAS  Google Scholar 

  89. Adams JC, Watt FM. Regulation of development and differentiation by extracellular matrix. Dev Biol 1993;117:1183–1198.

    CAS  Google Scholar 

  90. Rao CN, Marguiles IMK, Tralka TS, Terranova VP, Madri JA, Liotta LA. Isolation of a subunit of laminin and its role in molecular structure of tumour cell attachment. J Biol Chem 1982;257:9740–9744.

    PubMed  CAS  Google Scholar 

  91. McCarthy JB, Palm SL, Furcht LT. Migration by haptotaxis of a Schwann cell tumor line to a basement glycoprotein laminin. J Cell Biol 1983;97:772–777.

    Article  PubMed  CAS  Google Scholar 

  92. McCarthy JB, Furcht LT. Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro. J Cell Biol 1984;98:1474–1480.

    Article  PubMed  CAS  Google Scholar 

  93. Pellegrini R, Martignone S, Tagliabue E, et al. Prognostic significance of laminin production in relation with its receptor expression in human breast carcinomas. Breast Cancer Res Treat 1995;35:195–199.

    Article  PubMed  CAS  Google Scholar 

  94. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 1995;130:503–506.

    Article  PubMed  CAS  Google Scholar 

  95. Bornstein P. Thrombospondins as matricellular modulators of cell function. J Clin Invest 2001;107:929–934.

    PubMed  CAS  Google Scholar 

  96. Ohta Y, Shridhar V, Kalemkerian GP, Bright RK, Watanabe Y, Pass HI. Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma. Cancer 1999;85:2570–2576.

    Article  PubMed  CAS  Google Scholar 

  97. Varani J, Rister BL, Hughes LA, Carey TE, Fligiel SEG, Dixit VM. Characterisation of thrombospondin synthesis, secretion and cell surface expression by human tumour cells. Clin Exp Metastasis 1989;7:265–276.

    Article  PubMed  CAS  Google Scholar 

  98. Starcher BC. Lung elastin and matrix. Chest 2000; 117(suppl):229S–234S.

    PubMed  CAS  Google Scholar 

  99. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 1995;130:503–506.

    Article  PubMed  CAS  Google Scholar 

  100. Fülöp T, Larbi A. Putative role of 67 kDa elastin-laminin receptor in tumour invasion. Semin Cancer Biol 2002;12:219–229.

    Article  PubMed  CAS  Google Scholar 

  101. Blood CH, Sasse J, Brodt P, Zetter BR. Identification of a tumour cell receptor for VGVAPG, an elastin-derived chemotactic peptide. J Cell Biol 1988:107.

    Google Scholar 

  102. Martignone S, Menard S, Bufalino R, et al. Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J Nat Cancer Inst 1993;85:398–402.

    PubMed  CAS  Google Scholar 

  103. Farquhar MG. The glomerular basement membrane: a selective macromolecular filter. In: Hay ED, ed. Cell Biology of Extracellular Matrix. New York: Plenum, 1981:335–378.

    Google Scholar 

  104. Kjellén L, Lindahl U. Structure and functions of proteoglycans. Annu Rev Biochem 1991;60:853–856.

    Google Scholar 

  105. Laurent TC, Fraser JRE. Hyaluronan. FASEB J 1992;6:2397–2404.

    PubMed  CAS  Google Scholar 

  106. Toole BP. Hyaluronan promotes the malignant phenotype. Glycobiology 2002;12:37R–42R.

    Article  PubMed  CAS  Google Scholar 

  107. Meyer K, Chaffee E. Hyaluronic acid in pleural fluid associated with malignant tumour involving pleura and peritoneum. Proc Soc Exp Biol Med 1939;42:797–800.

    CAS  Google Scholar 

  108. Arai H, Endo M, Sasai Y, et al. Histochemical demonstration of hyaluronic acid in a case of pleural mesothelioma. Am Rev Respir Dis 1975;111:699–702.

    PubMed  CAS  Google Scholar 

  109. Arai H, Kang K, Sato H, et al. Significance of the quantification and demonstration of hyaluronic acid in tissue speciments from the diagnosis of pleural mesothelioma. Am Rev Respir Dis 1979;120:529–532.

    PubMed  CAS  Google Scholar 

  110. Wagner JC, Munday DE, Harington JS. Histochemical demonstration of hyaluronic acid in pleural mesotheliomas. J Pathol Bacteriol 1962;84:73–78.

    Article  PubMed  CAS  Google Scholar 

  111. Roboz J, Greaves J, Silides D, Chachinian P, Holland JF. Hyaluronic acid content of effusions as a diagnostic aid for malignant mesothelioma. Cancer Res 1985;45:1850–1854.

    PubMed  CAS  Google Scholar 

  112. Frebourg T, Lerebours G, Delpech B, et al. Serum hyaluronate in malignant pleural mesothelioma. Cancer 1987;59:2104–2107.

    Article  PubMed  CAS  Google Scholar 

  113. Pettersson T, Fröseth B, Riska H, Klockars M. Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma. Chest 1988;94:1037–1039.

    PubMed  CAS  Google Scholar 

  114. Thylen A, Levin-Jacobsen AM, Hjerpe A, Martensson G. Immunohistochemical differences between hyaluronan-and non-hyaluronan-producing malignant mesothelioma. Eur Respir J 1997;10:404–408.

    Article  PubMed  CAS  Google Scholar 

  115. Söderblom T, Pettersson T, Nyberg P, Teppo AM, Linko L, Riska H. High pleural fluid hyaluronan concentrations in rheumatoid arthritis. Eur Respir J 1999;13:519–522.

    Article  PubMed  Google Scholar 

  116. Asplund T, Versnel MA, Laurent TC, Heldin P. Human mesothelioma cells produce factors that stimulate the production of hyaluronan by mesothelial cells and fibroblasts. Cancer Res 1993;53:388–392.

    PubMed  CAS  Google Scholar 

  117. Dobra K, Andang M, Syrokou A, Karamanos NK, Hjerpe A. Differentiation of mesothelioma cells is influenced by the expression of proteoglycans. Exp Cell Res 2000;258:12–22.

    Article  PubMed  CAS  Google Scholar 

  118. Klominek J, Robért K-H, Hjerpe A, Wickström B, Gahrton G. Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. Cancer Res 1989;49:6118–6122.

    PubMed  CAS  Google Scholar 

  119. Tzanakakis GN, Karamanos NK, Klominek J, Hjerpe A. Glycosaminoglycans from two human malignant mesothelioma cell lines: determination, distribution, and effect of platelet-derived growth factor on their synthesis. Biochem Cell Biol 1995;73:59–66.

    Article  PubMed  CAS  Google Scholar 

  120. Nasreen N, Mohammed KA, Hardwick J, et al. Low molecular weight hyaluronan induces malignant mesothelioma cell (MMC) proliferation and haptotaxis: role of CD44 receptor in MMC proliferation and haptotaxis: Immunohistochemical localization of transforming growth factor beta isoforms in asbestos-related diseases. Oncol Res 2002;13:71–78.

    PubMed  CAS  Google Scholar 

  121. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998:609–652.

    Google Scholar 

  122. Kumar-Singh S, Jacobs W, Dhaene K, et al. Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome. J Pathol 1998;186:300–305.

    Article  PubMed  CAS  Google Scholar 

  123. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990;8:365–400.

    Article  PubMed  CAS  Google Scholar 

  124. Ruoslahti E, Giancotti FG. Integrins and tumor cell dissemination. Cancer Cells 1989;1:119–126.

    PubMed  CAS  Google Scholar 

  125. Jones JL, Walker RA. Integrins: a role as signalling molecules. Mol Pathol 1999;52:208–213.

    Article  PubMed  CAS  Google Scholar 

  126. Friedrichs K, Ruiz P, Franke F, Gille I, Terpe HJ, Imhof BA. High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res 1995;55:901–906.

    PubMed  CAS  Google Scholar 

  127. Varner JA, Cheresh DA. Integrins and cancer. Curr Opin Cell Biol 1996;8:724–730.

    Article  PubMed  CAS  Google Scholar 

  128. Lukashev ME, Werb Z. ECM signalling: orchestrating cell behaviour and missbehaviour. Trends Cell Biol 1988;8:437–441.

    Article  Google Scholar 

  129. Giuffrida A, Vianale G, Di Muzio M, et al. Modulation of integrin expression on mesotheliomas: the role of different histotypes in invasiveness. Int J Oncol 1999;15:437–442.

    PubMed  CAS  Google Scholar 

  130. Rihn BH, Mohr S, McDowell SA, et al. Differential gene expression in mesothelioma. FEBS Lett 2000;480:95–100.

    Article  PubMed  CAS  Google Scholar 

  131. Barth TF, Bruderlein S, Rinaldi N, Mechtersheimer G, Moller P. Pleural mesothelioma mimics the integrin profile of activated, sessile rather than detached mesothelial cells. Int J Cancer 1997;72:77–86.

    Article  PubMed  CAS  Google Scholar 

  132. Hayman EG, Pierschbacher MD, Ohgren Y, Ruoslahti E. Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci USA 1983;80:4003–4007.

    Article  PubMed  CAS  Google Scholar 

  133. Boylan AM, Sanan DA, Sheppard D, Broaddus VC. Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5. J Clin Invest 1995;96:1987–2001.

    Article  PubMed  CAS  Google Scholar 

  134. Eliceiri BP. Integrin and growth factor receptor crosstalk. Circ Res 2001;89:1104–1110.

    PubMed  CAS  Google Scholar 

  135. Raines EW, Ross R. Platelet-derived growth factor in vivo. In: Westermark B, Sorg C, eds. Biology of Platelet-Derived Growth Factor. Basel: Karger, 1993:74–114.

    Google Scholar 

  136. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995;108:754–758.

    PubMed  CAS  Google Scholar 

  137. Gottesman M. The role of proteases in cancer. Semin Cancer Biol 1990;1:97–100.

    Google Scholar 

  138. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327–336.

    Article  PubMed  CAS  Google Scholar 

  139. McCawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 2000;6:149–156.

    Article  PubMed  CAS  Google Scholar 

  140. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 2000;10:415–433.

    Article  PubMed  CAS  Google Scholar 

  141. Chang C, Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 2001;11:S37–43.

    PubMed  CAS  Google Scholar 

  142. Marshall BC, Santana A, Xu QP, et al. Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. J Clin Invest 1993;91:1792–1799.

    PubMed  CAS  Google Scholar 

  143. Liu Z, Ivanoff A, Klominek J. Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines. Int J Cancer 2001;91:638–643.

    Article  PubMed  CAS  Google Scholar 

  144. Hirano H, Tsuji M, Kizaki T, et al. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens, and Ki67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study. Med Electron Microsc 2002;35:16–23.

    Article  PubMed  CAS  Google Scholar 

  145. Liu Z, Klominek J. Regulation of matrix metalloproteases activity in malignant mesothelioma cell line by multiple growth factors. Thorax 2003.

    Google Scholar 

  146. Harvey P, Warn A, Dobbin S, et al. Expression of HGF/SF in mesothelioma cell lines and its effects on cell motility, proliferation and morphology. Br J Cancer 1998;77:1052–1059.

    PubMed  CAS  Google Scholar 

  147. Liu Z, Klominek J. Inhibition of proliferation, migration and matrix metalloproteases production in malignant mesothelioma cell lines by tyrosine kinase inhibitor ZD1839 (Iressa). Proceedings of the 6th Meeting of the International Mesothelioma Intrest Group Abstract 32, 2002.

    Google Scholar 

  148. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002;295:2387–2392.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Lung Medicine, Karolinska University Hospital at Huddinge, Stockholm, Sweden

    Julius Klominek MD, PhD

  2. Department of Clinical Immunology, Karolinska University Hospital at Huddinge, Stockholm, Sweden

    Dan Hauzenberger MD, PhD

Authors
  1. Julius Klominek MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dan Hauzenberger MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Thoracic Oncology, Barbara Ann Karmanos Cancer Institute, Harper University Hospital, USA

    Harvey I. Pass MD (Chief and Professor of Surgery and Oncology) (Chief and Professor of Surgery and Oncology)

  2. Wayne State University School of Medicine, Detroit, MI, 48201, USA

    Harvey I. Pass MD (Chief and Professor of Surgery and Oncology) (Chief and Professor of Surgery and Oncology)

  3. Nevada Cancer Institute, USA

    Nicholas J. Vogelzang MD (Director and Clinical Professor) (Director and Clinical Professor)

  4. Department of Internal Medicine, University of Nevada School of Medicine, Las Vegas, NV, 81935, USA

    Nicholas J. Vogelzang MD (Director and Clinical Professor) (Director and Clinical Professor)

  5. Thoracic Oncology, Cardinal Bernardin Cancer Center, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, 60153, USA

    Michele Carbone MD, PhD (Professor of Pathology, Director) (Professor of Pathology, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Klominek, J., Hauzenberger, D. (2005). Extracellular Matrix and Mesothelioma: Some Clues to the Invasive Behavior of Mesothelioma. In: Pass, H.I., Vogelzang, N.J., Carbone, M. (eds) Malignant Mesothelioma. Springer, New York, NY. https://doi.org/10.1007/0-387-28274-2_11

Download citation

  • DOI: https://doi.org/10.1007/0-387-28274-2_11

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-22949-2

  • Online ISBN: 978-0-387-28274-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation